Jan Moynihan
Concepts (370)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Stress, Psychological | 10 | 1992 | 117 |
Why?
| Herpesvirus 1, Human | 10 | 1994 | 28 |
Why?
| Cytokines | 13 | 1995 | 207 |
Why?
| Spleen | 26 | 1989 | 129 |
Why?
| Mice, Inbred BALB C | 29 | 1990 | 176 |
Why?
| Antibody Formation | 15 | 1989 | 89 |
Why?
| Stress, Physiological | 8 | 1990 | 76 |
Why?
| Interleukin-6 | 7 | 2000 | 145 |
Why?
| T-Lymphocytes | 12 | 1989 | 182 |
Why?
| Sympathetic Nervous System | 8 | 1992 | 43 |
Why?
| Personality | 2 | 2008 | 41 |
Why?
| Herpes Simplex | 4 | 1994 | 31 |
Why?
| Neuroimmunomodulation | 5 | 1993 | 7 |
Why?
| Immunity | 6 | 1989 | 46 |
Why?
| Hemocyanin | 17 | 1989 | 16 |
Why?
| Mice | 47 | 1989 | 623 |
Why?
| Interferon-gamma | 10 | 1994 | 133 |
Why?
| Interleukin-2 | 11 | 1990 | 71 |
Why?
| Immune System | 5 | 1990 | 43 |
Why?
| Sympathectomy, Chemical | 8 | 1994 | 6 |
Why?
| Interleukin-4 | 6 | 1994 | 62 |
Why?
| Narcotics | 2 | 2005 | 29 |
Why?
| Morphine | 2 | 2005 | 38 |
Why?
| Nervous System Physiological Phenomena | 2 | 1998 | 12 |
Why?
| Lymphocyte Activation | 10 | 1989 | 137 |
Why?
| Animals | 53 | 1989 | 1031 |
Why?
| Electroshock | 4 | 1992 | 11 |
Why?
| Temperament | 1 | 2011 | 14 |
Why?
| Motor Activity | 3 | 2004 | 104 |
Why?
| Antibodies, Viral | 5 | 1992 | 104 |
Why?
| Male | 47 | 1989 | 1553 |
Why?
| Depression | 5 | 2000 | 118 |
Why?
| Health Behavior | 1 | 2011 | 61 |
Why?
| Psoriasis | 1 | 2010 | 17 |
Why?
| Oxidopamine | 13 | 1992 | 21 |
Why?
| Aging | 3 | 1986 | 275 |
Why?
| Gender Identity | 1 | 2008 | 18 |
Why?
| Mice, Inbred C57BL | 15 | 1992 | 318 |
Why?
| Killer Cells, Natural | 8 | 1990 | 62 |
Why?
| Attitude to Health | 1 | 2011 | 106 |
Why?
| Psychoneuroimmunology | 1 | 2008 | 5 |
Why?
| Continental Population Groups | 1 | 2008 | 85 |
Why?
| Immunity, Innate | 3 | 2001 | 60 |
Why?
| Hyperkinesis | 1 | 2007 | 5 |
Why?
| Ethnic Groups | 1 | 2008 | 95 |
Why?
| Mifepristone | 4 | 1994 | 30 |
Why?
| Pituitary-Adrenal System | 2 | 1998 | 19 |
Why?
| Hypothalamo-Hypophyseal System | 2 | 1998 | 25 |
Why?
| Skin Diseases | 1 | 2008 | 69 |
Why?
| Immunoglobulin G | 10 | 1985 | 191 |
Why?
| Hormone Antagonists | 3 | 1998 | 26 |
Why?
| Sympatholytics | 9 | 1998 | 7 |
Why?
| Encephalitis | 1 | 2005 | 29 |
Why?
| Dexamethasone | 2 | 1994 | 109 |
Why?
| Antigens | 7 | 1992 | 66 |
Why?
| Analysis of Variance | 7 | 1990 | 339 |
Why?
| Immunosuppression | 1 | 2004 | 47 |
Why?
| Inflammation | 4 | 2002 | 208 |
Why?
| Immunocompromised Host | 1 | 2004 | 70 |
Why?
| Antigens, Viral | 2 | 2001 | 53 |
Why?
| Enzyme-Linked Immunosorbent Assay | 8 | 1985 | 224 |
Why?
| Geriatric Assessment | 1 | 2004 | 63 |
Why?
| Cells, Cultured | 7 | 1998 | 447 |
Why?
| Odors | 2 | 1994 | 5 |
Why?
| Social Support | 1 | 2004 | 111 |
Why?
| Vaccination | 1 | 2004 | 92 |
Why?
| Corticosterone | 4 | 1996 | 25 |
Why?
| Brain | 2 | 2005 | 305 |
Why?
| Exudates and Transudates | 1 | 2002 | 15 |
Why?
| Primary Health Care | 4 | 2008 | 151 |
Why?
| Norepinephrine | 10 | 1992 | 68 |
Why?
| Macrophages | 1 | 2004 | 148 |
Why?
| Autoimmune Diseases | 4 | 1990 | 49 |
Why?
| Influenza Vaccines | 1 | 2004 | 70 |
Why?
| Epstein-Barr Virus Infections | 1 | 2001 | 13 |
Why?
| Female | 25 | 1989 | 1643 |
Why?
| Physical Exertion | 1 | 2001 | 46 |
Why?
| Humans | 26 | 1985 | 1856 |
Why?
| Influenza, Human | 1 | 2004 | 94 |
Why?
| Immunoglobulin M | 7 | 1985 | 81 |
Why?
| Handling (Psychology) | 2 | 1990 | 3 |
Why?
| Endorphins | 1 | 2000 | 15 |
Why?
| Immunity, Cellular | 4 | 1991 | 85 |
Why?
| Urban Population | 3 | 2008 | 80 |
Why?
| Fatigue | 1 | 2001 | 48 |
Why?
| Aged | 12 | 1986 | 988 |
Why?
| Aged, 80 and over | 9 | 2000 | 599 |
Why?
| T-Lymphocytes, Helper-Inducer | 3 | 1989 | 38 |
Why?
| Respiratory Tract Infections | 1 | 2001 | 57 |
Why?
| Preoperative Care | 1 | 2000 | 93 |
Why?
| Psychotherapy | 1 | 2000 | 46 |
Why?
| Heart Rate | 1 | 2001 | 138 |
Why?
| Receptors, Glucocorticoid | 1 | 1998 | 26 |
Why?
| Disease Models, Animal | 3 | 1993 | 349 |
Why?
| Endocrine System | 1 | 1998 | 9 |
Why?
| Dehydroepiandrosterone | 1 | 1998 | 16 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2000 | 210 |
Why?
| Pheromones | 2 | 1993 | 3 |
Why?
| Housing, Animal | 2 | 1993 | 7 |
Why?
| Th1 Cells | 3 | 2001 | 33 |
Why?
| Lipopolysaccharides | 5 | 1994 | 98 |
Why?
| Time Factors | 6 | 1993 | 896 |
Why?
| Lung Neoplasms | 2 | 1990 | 159 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2002 | 243 |
Why?
| Concanavalin A | 3 | 1994 | 25 |
Why?
| Multiple Organ Failure | 3 | 2000 | 17 |
Why?
| Th2 Cells | 3 | 2001 | 36 |
Why?
| Psychiatric Status Rating Scales | 4 | 2000 | 99 |
Why?
| Communicable Diseases | 1 | 1996 | 22 |
Why?
| Parent-Child Relations | 2 | 2007 | 53 |
Why?
| Immunoglobulin kappa-Chains | 2 | 1985 | 14 |
Why?
| Neoplasms, Experimental | 2 | 1992 | 72 |
Why?
| Neoplasms | 1 | 2003 | 239 |
Why?
| Immune Tolerance | 3 | 1989 | 72 |
Why?
| Middle Aged | 12 | 2000 | 1161 |
Why?
| Cyclophosphamide | 3 | 1989 | 82 |
Why?
| Social Isolation | 1 | 1994 | 18 |
Why?
| Listeriosis | 3 | 2001 | 4 |
Why?
| Macrophages, Peritoneal | 2 | 2002 | 12 |
Why?
| Adult | 11 | 1986 | 1317 |
Why?
| Interleukin-12 | 2 | 2001 | 27 |
Why?
| Breast Neoplasms | 1 | 2000 | 185 |
Why?
| Leukocyte Count | 6 | 1990 | 94 |
Why?
| Murine Acquired Immunodeficiency Syndrome | 2 | 2002 | 3 |
Why?
| Cholera Toxin | 1 | 1992 | 17 |
Why?
| Simplexvirus | 1 | 1992 | 33 |
Why?
| Adjuvants, Immunologic | 2 | 1992 | 73 |
Why?
| Sympathectomy | 3 | 1998 | 11 |
Why?
| Nickel | 1 | 1991 | 21 |
Why?
| Leukocytes | 2 | 2002 | 94 |
Why?
| Zinc | 1 | 1991 | 37 |
Why?
| Lymphocytes | 2 | 1989 | 142 |
Why?
| Interleukin-1 | 2 | 2001 | 109 |
Why?
| Psychophysiology | 1 | 2011 | 15 |
Why?
| Systemic Inflammatory Response Syndrome | 2 | 2000 | 9 |
Why?
| Longitudinal Studies | 2 | 2001 | 195 |
Why?
| Seasonal Affective Disorder | 1 | 2010 | 7 |
Why?
| Conditioning, Classical | 3 | 1993 | 17 |
Why?
| Phototherapy | 1 | 2010 | 13 |
Why?
| Behavior | 1 | 2011 | 36 |
Why?
| Models, Immunological | 1 | 2011 | 40 |
Why?
| Interleukin-10 | 2 | 2001 | 38 |
Why?
| Biological Markers | 3 | 2000 | 262 |
Why?
| Dose-Response Relationship, Drug | 2 | 2002 | 431 |
Why?
| Severity of Illness Index | 5 | 2000 | 358 |
Why?
| Insulin-Like Growth Factor I | 2 | 2001 | 64 |
Why?
| Sleep Disorders | 1 | 2011 | 32 |
Why?
| Carcinoma | 1 | 1992 | 109 |
Why?
| African Continental Ancestry Group | 1 | 2011 | 80 |
Why?
| Death, Sudden | 1 | 2009 | 23 |
Why?
| Immunoglobulin mu-Chains | 2 | 1985 | 10 |
Why?
| Immunization | 3 | 1990 | 85 |
Why?
| Morbidity | 1 | 2009 | 62 |
Why?
| Reference Values | 1 | 2011 | 278 |
Why?
| Life Change Events | 1 | 2009 | 50 |
Why?
| Minority Groups | 1 | 2008 | 38 |
Why?
| Sodium Chloride | 1 | 1989 | 77 |
Why?
| Questionnaires | 4 | 2001 | 360 |
Why?
| Personality Inventory | 1 | 2008 | 52 |
Why?
| New York | 2 | 2008 | 422 |
Why?
| Arginase | 1 | 2007 | 3 |
Why?
| Swimming | 1 | 2007 | 6 |
Why?
| RNA, Messenger | 2 | 2005 | 394 |
Why?
| Exploratory Behavior | 1 | 2007 | 15 |
Why?
| Virus Replication | 2 | 1992 | 90 |
Why?
| Eating | 1 | 2007 | 37 |
Why?
| Clone Cells | 2 | 1989 | 92 |
Why?
| Mice, Inbred C3H | 4 | 1989 | 86 |
Why?
| Agammaglobulinemia | 1 | 1986 | 14 |
Why?
| Parents | 1 | 2008 | 89 |
Why?
| Mannitol | 1 | 2005 | 29 |
Why?
| Ataxia | 1 | 2005 | 17 |
Why?
| Paralysis | 1 | 2005 | 37 |
Why?
| Behavior, Animal | 1 | 2007 | 77 |
Why?
| Administration, Oral | 2 | 1992 | 170 |
Why?
| Age Factors | 3 | 1993 | 480 |
Why?
| Antigen-Presenting Cells | 2 | 1996 | 40 |
Why?
| Peritoneal Cavity | 2 | 2002 | 28 |
Why?
| Random Allocation | 2 | 1990 | 160 |
Why?
| Central Nervous System Viral Diseases | 1 | 2005 | 4 |
Why?
| Immunoglobulin Light Chains | 1 | 1985 | 10 |
Why?
| B-Lymphocytes | 3 | 1989 | 134 |
Why?
| Social Behavior | 2 | 1994 | 53 |
Why?
| Interferons | 1 | 2005 | 39 |
Why?
| Immunoglobulin Heavy Chains | 1 | 1985 | 24 |
Why?
| Blood-Brain Barrier | 1 | 2005 | 63 |
Why?
| Mass Vaccination | 1 | 2004 | 13 |
Why?
| Polyethylene Glycols | 1 | 2005 | 45 |
Why?
| Orthomyxoviridae | 1 | 2004 | 34 |
Why?
| Macrophage Activation | 1 | 2004 | 42 |
Why?
| Neoplasm Metastasis | 2 | 1992 | 112 |
Why?
| Affect | 1 | 2004 | 55 |
Why?
| Antigens, CD95 | 2 | 2000 | 16 |
Why?
| Cell Count | 2 | 2001 | 163 |
Why?
| Macrophages, Alveolar | 1 | 2004 | 44 |
Why?
| Drug Interactions | 1 | 2004 | 111 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 51 |
Why?
| Autonomic Nervous System Diseases | 1 | 2003 | 12 |
Why?
| Peritoneum | 1 | 2002 | 14 |
Why?
| Nursing Homes | 1 | 2004 | 55 |
Why?
| Peritonitis | 1 | 2002 | 28 |
Why?
| Mitogens | 1 | 2002 | 31 |
Why?
| Cell Division | 2 | 1992 | 273 |
Why?
| Leukocytes, Mononuclear | 2 | 2000 | 67 |
Why?
| Nadolol | 1 | 2002 | 5 |
Why?
| Influenza A virus | 1 | 2004 | 63 |
Why?
| Nitric Oxide | 1 | 2004 | 85 |
Why?
| Immunohistochemistry | 1 | 2005 | 355 |
Why?
| Coronary Disease | 1 | 2005 | 94 |
Why?
| Anger | 1 | 2001 | 14 |
Why?
| Adrenergic beta-Antagonists | 1 | 2002 | 47 |
Why?
| Cytotoxicity Tests, Immunologic | 1 | 2001 | 23 |
Why?
| Leptin | 1 | 2001 | 11 |
Why?
| Depressive Disorder | 1 | 2005 | 76 |
Why?
| Antibodies, Monoclonal | 2 | 1990 | 241 |
Why?
| Cell Separation | 1 | 2002 | 110 |
Why?
| Neoplasm Transplantation | 2 | 1990 | 67 |
Why?
| Membrane Glycoproteins | 2 | 2000 | 154 |
Why?
| Drinking Behavior | 2 | 1989 | 5 |
Why?
| Nitrates | 1 | 2000 | 27 |
Why?
| Flow Cytometry | 3 | 1989 | 216 |
Why?
| Body Weight | 1 | 2001 | 178 |
Why?
| Critical Illness | 1 | 2000 | 34 |
Why?
| Naltrexone | 1 | 2000 | 8 |
Why?
| Narcotic Antagonists | 1 | 2000 | 13 |
Why?
| Analgesia | 1 | 2000 | 27 |
Why?
| Cross-Sectional Studies | 3 | 2001 | 253 |
Why?
| Coronary Artery Disease | 1 | 2001 | 56 |
Why?
| Feasibility Studies | 1 | 2000 | 144 |
Why?
| Sympathomimetics | 1 | 1998 | 4 |
Why?
| Pulmonary Alveoli | 1 | 2001 | 80 |
Why?
| Gene Expression Regulation | 1 | 2005 | 277 |
Why?
| Health Status | 1 | 2001 | 127 |
Why?
| Health | 1 | 1998 | 14 |
Why?
| Immunity, Mucosal | 1 | 1998 | 16 |
Why?
| Tumor Cells, Cultured | 2 | 1990 | 233 |
Why?
| Antigens, CD3 | 1 | 1998 | 37 |
Why?
| Mucous Membrane | 1 | 1998 | 37 |
Why?
| Brain Chemistry | 1 | 1998 | 60 |
Why?
| Treatment Outcome | 2 | 2000 | 661 |
Why?
| Neurosecretory Systems | 1 | 1998 | 18 |
Why?
| Disease | 1 | 1998 | 27 |
Why?
| Eye | 1 | 1998 | 37 |
Why?
| Nervous System | 1 | 1998 | 52 |
Why?
| Lymphoid Tissue | 1 | 1998 | 34 |
Why?
| Apoptosis | 2 | 2000 | 265 |
Why?
| Cytotoxicity, Immunologic | 2 | 1993 | 54 |
Why?
| Immunologic Deficiency Syndromes | 1 | 1996 | 30 |
Why?
| Disease Susceptibility | 1 | 1996 | 61 |
Why?
| Sialoglycoproteins | 1 | 1996 | 31 |
Why?
| Arteriosclerosis | 1 | 1996 | 54 |
Why?
| Chromatography, High Pressure Liquid | 3 | 1993 | 121 |
Why?
| Drug Implants | 1 | 1994 | 15 |
Why?
| Lymphocyte Subsets | 1 | 1994 | 26 |
Why?
| Antigens, CD | 1 | 1996 | 128 |
Why?
| Logistic Models | 2 | 2001 | 251 |
Why?
| Monocytes | 1 | 1996 | 124 |
Why?
| Rats | 3 | 1996 | 530 |
Why?
| Genetic Predisposition to Disease | 1 | 1996 | 131 |
Why?
| Anesthesia, General | 1 | 1994 | 42 |
Why?
| Adrenergic Fibers | 1 | 1993 | 13 |
Why?
| Carbon Dioxide | 1 | 1994 | 90 |
Why?
| Prospective Studies | 2 | 2007 | 545 |
Why?
| Nerve Endings | 1 | 1992 | 12 |
Why?
| Digestive System | 1 | 1992 | 21 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 1992 | 37 |
Why?
| Denervation | 1 | 1992 | 19 |
Why?
| Hypersensitivity, Delayed | 1 | 1992 | 35 |
Why?
| Lupus Erythematosus, Systemic | 1 | 1993 | 52 |
Why?
| Foot | 1 | 1992 | 28 |
Why?
| Receptors, Adrenergic, beta | 1 | 1992 | 35 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 1992 | 52 |
Why?
| Fas Ligand Protein | 2 | 2000 | 10 |
Why?
| Receptors, Interleukin-2 | 1 | 1990 | 31 |
Why?
| Clinical Medicine | 1 | 2010 | 10 |
Why?
| Feeding Behavior | 1 | 1990 | 29 |
Why?
| Axons | 1 | 1992 | 66 |
Why?
| Child, Preschool | 2 | 2007 | 554 |
Why?
| Glucocorticoids | 1 | 1992 | 107 |
Why?
| Health Status Disparities | 1 | 2011 | 25 |
Why?
| Seasons | 1 | 2010 | 64 |
Why?
| Immunoglobulin gamma-Chains | 1 | 1990 | 2 |
Why?
| Diet | 1 | 1991 | 87 |
Why?
| Animals, Laboratory | 1 | 1990 | 8 |
Why?
| Bereavement | 1 | 2009 | 9 |
Why?
| Socioeconomic Factors | 1 | 2011 | 144 |
Why?
| Neutrophils | 2 | 2001 | 114 |
Why?
| Blood Cell Count | 1 | 1989 | 31 |
Why?
| Nerve Fibers | 2 | 1998 | 45 |
Why?
| Cause of Death | 1 | 2009 | 82 |
Why?
| Epitopes | 1 | 1989 | 86 |
Why?
| Activities of Daily Living | 1 | 2011 | 122 |
Why?
| Infection | 1 | 1989 | 57 |
Why?
| Case-Control Studies | 2 | 2001 | 283 |
Why?
| Depressive Disorder, Major | 1 | 2010 | 36 |
Why?
| Cell Communication | 1 | 1989 | 72 |
Why?
| Survival Analysis | 2 | 2000 | 205 |
Why?
| Child | 2 | 2007 | 749 |
Why?
| Immunosuppressive Agents | 1 | 1989 | 102 |
Why?
| Family Health | 1 | 2008 | 69 |
Why?
| Cytomegalovirus | 1 | 2008 | 42 |
Why?
| Epidemiology | 1 | 2007 | 15 |
Why?
| Chronic Disease | 1 | 2009 | 267 |
Why?
| Herpesvirus 6, Human | 1 | 2008 | 22 |
Why?
| Obesity | 1 | 2009 | 149 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2008 | 91 |
Why?
| Immunoglobulins | 2 | 1994 | 54 |
Why?
| Kinetics | 1 | 1989 | 349 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2008 | 113 |
Why?
| Immunoglobulin A | 1 | 1985 | 39 |
Why?
| Liver | 1 | 1990 | 248 |
Why?
| Cell Line | 1 | 1989 | 375 |
Why?
| Retrospective Studies | 1 | 2010 | 653 |
Why?
| C-Reactive Protein | 1 | 2005 | 54 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2003 | 14 |
Why?
| Phagocytes | 1 | 2002 | 19 |
Why?
| Desipramine | 1 | 2003 | 20 |
Why?
| Lung | 1 | 1990 | 232 |
Why?
| Injections, Intraperitoneal | 1 | 2002 | 57 |
Why?
| Retroviridae | 1 | 2002 | 36 |
Why?
| Oxidation-Reduction | 1 | 2003 | 124 |
Why?
| Cell Culture Techniques | 1 | 2002 | 74 |
Why?
| Infant, Newborn | 1 | 1986 | 389 |
Why?
| Disease Progression | 1 | 2003 | 244 |
Why?
| Diagnosis-Related Groups | 1 | 2000 | 21 |
Why?
| Solubility | 1 | 2000 | 75 |
Why?
| Hydrocortisone | 1 | 2001 | 65 |
Why?
| Body Mass Index | 1 | 2001 | 122 |
Why?
| Pilot Projects | 1 | 2001 | 264 |
Why?
| Up-Regulation | 1 | 2001 | 183 |
Why?
| Cell Differentiation | 2 | 1994 | 262 |
Why?
| Arcuate Nucleus | 1 | 1998 | 5 |
Why?
| Olfactory Bulb | 1 | 1998 | 15 |
Why?
| Arginine Vasopressin | 1 | 1998 | 21 |
Why?
| Corticotropin-Releasing Hormone | 1 | 1998 | 10 |
Why?
| Adrenocorticotropic Hormone | 1 | 1998 | 31 |
Why?
| Survival Rate | 1 | 2001 | 250 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 1998 | 35 |
Why?
| Prosencephalon | 1 | 1998 | 29 |
Why?
| Feedback | 1 | 1998 | 54 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 1998 | 30 |
Why?
| Antigens, CD43 | 1 | 1996 | 9 |
Why?
| Lymphocyte Cooperation | 1 | 1996 | 12 |
Why?
| Rats, Inbred F344 | 1 | 1998 | 80 |
Why?
| Ovalbumin | 1 | 1996 | 32 |
Why?
| Mice, Inbred DBA | 1 | 1996 | 38 |
Why?
| Rats, Inbred Lew | 1 | 1996 | 17 |
Why?
| Prognosis | 1 | 2000 | 388 |
Why?
| Cell Adhesion | 1 | 1996 | 113 |
Why?
| Mice, Transgenic | 1 | 1996 | 209 |
Why?
| Splenomegaly | 1 | 1993 | 14 |
Why?
| Lymphokines | 1 | 1994 | 61 |
Why?
| Mice, Mutant Strains | 1 | 1993 | 77 |
Why?
| Organ Size | 1 | 1993 | 118 |
Why?
| Gene Expression | 1 | 1996 | 291 |
Why?
| T-Lymphocyte Subsets | 1 | 1993 | 70 |
Why?
| Fixatives | 1 | 1990 | 13 |
Why?
| Models, Biological | 1 | 1996 | 410 |
Why?
| Formaldehyde | 1 | 1990 | 18 |
Why?
| Milk | 1 | 1990 | 16 |
Why?
| False Positive Reactions | 1 | 1990 | 71 |
Why?
| Cross Reactions | 1 | 1990 | 63 |
Why?
| Cell Membrane Permeability | 1 | 1990 | 57 |
Why?
| Mice, Inbred Strains | 1 | 1990 | 118 |
Why?
| Polymers | 1 | 1990 | 60 |
Why?
| Species Specificity | 1 | 1990 | 186 |
Why?
| Xenopus laevis | 1 | 1990 | 49 |
Why?
| Antibodies | 1 | 1990 | 159 |
Why?
| Sex Factors | 1 | 1990 | 284 |
Why?
| DNA | 1 | 1990 | 262 |
Why?
|
|
Moynihan's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
